Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities APLS - Apellis Pharmaceuticals, Inc.
394 M
LAST VALUE
0.29%
2 YEAR CAGR
24.50%
5 YEAR CAGR
49.31%
10 YEAR CAGR